Detalhe da pesquisa
1.
Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
Mol Carcinog
; 63(5): 991-1008, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376345
2.
OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer.
Cell Mol Life Sci
; 80(9): 272, 2023 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646890
3.
Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer.
Mol Cancer
; 21(1): 193, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36203195
4.
Anwulignan is a novel JAK1 inhibitor that suppresses non-small cell lung cancer growth.
J Cell Mol Med
; 25(5): 2645-2654, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33523587
5.
Harmaline isolated from Peganum harmala suppresses growth of esophageal squamous cell carcinoma through targeting mTOR.
Phytother Res
; 35(11): 6377-6388, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34545650
6.
Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets.
JCI Insight
; 9(10)2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652547
7.
Targeting FGFR1 by ß,ß-dimethylacrylalkannin suppresses the proliferation of colorectal cancer in cellular and xenograft models.
Phytomedicine
; 129: 155612, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669968
8.
Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases.
Signal Transduct Target Ther
; 8(1): 148, 2023 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37029108
9.
Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth.
J Exp Clin Cancer Res
; 42(1): 97, 2023 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088855
10.
Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinoma.
Cell Oncol (Dordr)
; 45(1): 179-191, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35102488
11.
Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase.
Elife
; 112022 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082941
12.
A novel lncRNA MTAR1 promotes cancer development through IGF2BPs mediated post-transcriptional regulation of c-MYC.
Oncogene
; 41(42): 4736-4753, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36109629
13.
BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression.
Oncogene
; 41(3): 347-360, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750516
14.
Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A.
Cell Death Dis
; 13(2): 189, 2022 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35217647
15.
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo.
Acta Pharm Sin B
; 12(11): 4122-4137, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36386480
16.
Ethyl Ferulate Suppresses Esophageal Squamous Cell Carcinoma Tumor Growth Through Inhibiting the mTOR Signaling Pathway.
Front Oncol
; 11: 780011, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35155187
17.
3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo.
Front Cell Dev Biol
; 9: 638174, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33842463
18.
Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer.
Oncogene
; 39(43): 6733-6746, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32963350